Metabolomic characterization of human model of liver rejection identifies aberrancies linked to cyclooxygenase (COX) and nitric oxide synthase (NOS)

Nicholas J. Skill, Campbell M. Elliott, Brian Ceballos, Romil Saxena, Robert Pepin, Lisa Bettcher, Matthew Ellensberg, Daniel Raftery, Mary A. Maluccio, Burcin Ekser, Richard S. Mangus, Chandrashekhar A. Kubal

Research output: Contribution to journalArticle

Abstract

Background: Acute liver rejection (ALR), a significant complication of liver transplantation, burdens patients, healthcare payers, and the healthcare providers due to an increase in morbidity, cost, and resources. Despite clinical resolution, ALR is associated with an increased risk of graft loss. A unique protocol of delayed immunosuppression used in our institute provided a model to characterize metabolomic profiles in human ALR. Material/Methods: Twenty liver allograft biopsies obtained 48 hours after liver transplantation in the absence of immunosuppression were studied. Hepatic metabolites were quantitated in these biopsies by liquid chromatography and mass spectroscopy (LC/MS). Metabolite profiles were compared among: 1) biopsies with reperfusion injury but no histological evidence of rejection (n=7), 2) biopsies with histological evidence of moderate or severe rejection (n=5), and 3) biopsies with histological evidence of mild rejection (n=8). Results: There were 133 metabolites consistently detected by LC/MS and these were prioritized using variable importance to projection (VIP) analysis, comparing moderate or severe rejection vs. no rejection or mild rejection using partial least squares discriminant statistical analysis (PLS-DA). Twenty metabolites were identified as progressively different. Further PLS-DA using these metabolites identified 3 metabolites (linoleic acid, g-linolenic acid, and citrulline) which are associated with either cyclooxygenase or nitric oxide synthase functionality. Conclusions: Hepatic metabolic aberrancies associated with cyclooxygenase and nitric oxide synthase function occur contemporaneous with ALR. Additional studies are required to better characterize the role of these metabolic pathways to enhance utility of the metabolomics approach in diagnosis and outcomes of ALR.

Original languageEnglish (US)
Pages (from-to)341-349
Number of pages9
JournalAnnals of transplantation
Volume24
DOIs
StatePublished - Jan 1 2019

Keywords

  • Graft Rejection
  • Liver Transplantation
  • Metabolomics
  • Nitric Oxide Synthase
  • Prostaglandin-Endoperoxide Synthases

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Metabolomic characterization of human model of liver rejection identifies aberrancies linked to cyclooxygenase (COX) and nitric oxide synthase (NOS)'. Together they form a unique fingerprint.

  • Cite this

    Skill, N. J., Elliott, C. M., Ceballos, B., Saxena, R., Pepin, R., Bettcher, L., Ellensberg, M., Raftery, D., Maluccio, M. A., Ekser, B., Mangus, R. S., & Kubal, C. A. (2019). Metabolomic characterization of human model of liver rejection identifies aberrancies linked to cyclooxygenase (COX) and nitric oxide synthase (NOS). Annals of transplantation, 24, 341-349. https://doi.org/10.12659/AOT.913800